Class II · Moderate risk Terminated
Tazorac
Reason Failed Content Uniformity Specifications
FDA Drug Recalls
14,801 recalls, newest first
Class II · Moderate risk Terminated
Tazorac
Reason Failed Content Uniformity Specifications
Class II · Moderate risk Terminated
Methylprednisolone Acetate/Lidocaine HCl 40/10 mg/mL Injection
Reason Lack of Processing Controls: Isomeric Pharmacy Solution, LLC announces a voluntary field action for the Methylprednisolone Acetate/Lidocaine HCl 40/10 mg/mL Injection because the sterile injectable products were sterilized too long leading to potential difficulty resuspending particles.
Class II · Moderate risk Terminated
TESTOSTERONE CYPIONATE 200mg/ml
Reason Lack of Assurance of Sterility: Aluminum crimps do not fully seal the rubber stopper to the vial on all containers.
Class III · Low risk Terminated
5% Lidocaine HCL and 7.5% Dextrose Injection
Reason Failed Stability Specifications: The recalled lots did not meet the specification for color and pH throughout shelf life.
Class III · Low risk Terminated
DULOXETINE Delayed-Release Capsules
Reason Labeling; Incorrect or Missing Lot and/or Exp Date; incorrect expiration date on container label is 02/2019, correct expiration date should be 02/2018
Class III · Low risk Terminated
Carvediol Tablets
Reason Failed Impurities/Degradation Specifications
Class III · Low risk Terminated
Carvediol Tablets
Reason Failed Impurities/Degradation Specifications
Class III · Low risk Terminated
Carvediol Tablets
Reason Failed Impurities/Degradation Specifications
Class III · Low risk Terminated
Carvediol Tablets
Reason Failed Impurities/Degradation Specifications
Class III · Low risk Terminated
buPROPion Hydrochloride Extended Release Tablets USP
Reason Failed Dissolution Specifications
Class II · Moderate risk Terminated
Amoxicillin for Oral Suspension USP
Reason Superpotent drug: Out of specification test result for assay during stability testing.
Class II · Moderate risk Terminated
Diazepam Injection USP 10mg/2mL
Reason Crystallization: Product contains particulate identified to be crystallized active ingredient.
Class II · Moderate risk Terminated
Albuterol Sulfate Syrup
Reason Presence of Foreign Substance; presence of black particles describes generically as cellulose-based bundles of brown fibrous material.
Class II · Moderate risk Terminated
Alprazolam Extended-release Tablets
Reason Failed Dissolution Specifications
Class II · Moderate risk Terminated
Prostaglandin 200 mcg/ 0.1 mL -- 25 mL GLASS VIAL
Reason Lack of assurance of sterility: This recall includes of all unexpired lots medications containing Calcium Gluconate, Papaverine, Phentolamine, and /or Prostaglandin) due to unsubstantiated validation of beyond use dating.
Class II · Moderate risk Terminated
Papaverine 75 mg / Phentolamine 2.5 mg / Prostaglandin 25 mcg --…
Reason Lack of assurance of sterility: This recall includes of all unexpired lots medications containing Calcium Gluconate, Papaverine, Phentolamine, and /or Prostaglandin) due to unsubstantiated validation of beyond use dating.
Class II · Moderate risk Terminated
Papaverine 30 mg / Phentolamine 1 mg / mL -- 5 mL GLASS VIAL
Reason Lack of assurance of sterility: This recall includes of all unexpired lots medications containing Calcium Gluconate, Papaverine, Phentolamine, and /or Prostaglandin) due to unsubstantiated validation of beyond use dating.
Class II · Moderate risk Terminated
Calcium Gluconate 2.5% -- 20 mL PLASTIC SYRINGE
Reason Lack of assurance of sterility: This recall includes of all unexpired lots medications containing Calcium Gluconate, Papaverine, Phentolamine, and /or Prostaglandin) due to unsubstantiated validation of beyond use dating.
Class II · Moderate risk Terminated
Calcium Gluconate 1% -- 1000 mL VIAFLEX IV BAG
Reason Lack of assurance of sterility: This recall includes of all unexpired lots medications containing Calcium Gluconate, Papaverine, Phentolamine, and /or Prostaglandin) due to unsubstantiated validation of beyond use dating.
Class II · Moderate risk Terminated
Ondansetron Injection USP 40 mg/20 mL
Reason CGMP Deviations
Class II · Moderate risk Terminated
Eptifibatide Injection 75 mg/100 mL
Reason CGMP Deviations
Class II · Moderate risk Terminated
Linezolid Injection 600 mg/300 mL Rx Only
Reason CGMP Deviations
Class II · Moderate risk Terminated
ARGATROBAN Injection in 0.9% Sodium Chloride 250 mg/250 mL
Reason CGMP Deviations
Class II · Moderate risk Terminated
Oxacillin for Injection
Reason Presence of Particulate Matter; The firm received two product complaints for small, dark particulate matter identified in solution post reconstitution.